Literature DB >> 14511229

The MHC class I antigen presentation pathway: strategies for viral immune evasion.

Eric W Hewitt1.   

Abstract

Presumably because of the selective pressure exerted by the immune system, many viruses have evolved proteins that interfere with antigen presentation by major histocompatibility complex (MHC) class I molecules. These viruses utilize a whole variety of ingenious strategies to inhibit the MHC class I pathway. Viral proteins have been characterized that exploit bottlenecks in the MHC class I pathway, such as peptide translocation by the transporter associated with antigen processing. Alternatively, viral proteins can cause the degradation or mislocalization of MHC class I molecules. This is often achieved by the subversion of the host cell's own protein degradation and trafficking pathways. As a consequence elucidation of how these viral proteins act to subvert host cell function will continue to give important insights not only into virus-host interactions but also the function and mechanism of cellular pathways.

Mesh:

Substances:

Year:  2003        PMID: 14511229      PMCID: PMC1783040          DOI: 10.1046/j.1365-2567.2003.01738.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  81 in total

Review 1.  ER-associated degradation in protein quality control and cellular regulation.

Authors:  Randolph Y Hampton
Journal:  Curr Opin Cell Biol       Date:  2002-08       Impact factor: 8.382

2.  Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4.

Authors:  Hemmo H Meyer; Yanzhuang Wang; Graham Warren
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

3.  HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway.

Authors:  Anastassia D Blagoveshchenskaya; Laurel Thomas; Sylvain F Feliciangeli; Chien Hui Hung; Gary Thomas
Journal:  Cell       Date:  2002-12-13       Impact factor: 41.582

Review 4.  Assembly and export of MHC class I peptide ligands.

Authors:  Antony N Antoniou; Simon J Powis; Tim Elliott
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

5.  Quantitating protein synthesis, degradation, and endogenous antigen processing.

Authors:  Michael F Princiotta; Diana Finzi; Shu-Bing Qian; James Gibbs; Sebastian Schuchmann; Frank Buttgereit; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

6.  Powering the peptide pump: TAP crosstalk with energetic nucleotides.

Authors:  Peter M van Endert; Loredana Saveanu; Eric W Hewitt; Paul Lehner
Journal:  Trends Biochem Sci       Date:  2002-09       Impact factor: 13.807

7.  K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.

Authors:  P G Stevenson; J S May; X G Smith; S Marques; H Adler; U H Koszinowski; J P Simas; S Efstathiou
Journal:  Nat Immunol       Date:  2002-07-08       Impact factor: 25.606

8.  The active domain of the herpes simplex virus protein ICP47: a potent inhibitor of the transporter associated with antigen processing.

Authors:  L Neumann; W Kraas; S Uebel; G Jung; R Tampé
Journal:  J Mol Biol       Date:  1997-10-03       Impact factor: 5.469

9.  The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules.

Authors:  Margo H Furman; Neelendu Dey; Domenico Tortorella; Hidde L Ploegh
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein.

Authors:  Sungwook Lee; Boyoun Park; Kwangseog Ahn
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  134 in total

1.  Kinetics of immune responses in deer mice experimentally infected with Sin Nombre virus.

Authors:  Tony Schountz; Mariana Acuña-Retamar; Shira Feinstein; Joseph Prescott; Fernando Torres-Perez; Brendan Podell; Staci Peters; Chunyan Ye; William C Black; Brian Hjelle
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

2.  Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection.

Authors:  Cristina Toledo-Cornell; Silvane Santos; Gloria Orge; Marshall J Glesby; Edgar M Carvalho
Journal:  J Med Virol       Date:  2013-09-11       Impact factor: 2.327

3.  The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens.

Authors:  Sara Gredmark-Russ; Evelyn J Cheung; Marisa K Isaacson; Hidde L Ploegh; Gijsbert M Grotenbreg
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

Review 4.  Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence.

Authors:  Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-12       Impact factor: 6.237

5.  Human cytomegalovirus UL76 elicits novel aggresome formation via interaction with S5a of the ubiquitin proteasome system.

Authors:  Shin-Rung Lin; Meei Jyh Jiang; Hung-Hsueh Wang; Cheng-Hui Hu; Ming-Shan Hsu; Edward Hsi; Chang-Yih Duh; Shang-Kwei Wang
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

Review 6.  ACOD1 in immunometabolism and disease.

Authors:  Runliu Wu; Feng Chen; Nian Wang; Daolin Tang; Rui Kang
Journal:  Cell Mol Immunol       Date:  2020-06-29       Impact factor: 11.530

Review 7.  Natural killer cell cytotoxicity: how do they pull the trigger?

Authors:  Nicola J Topham; Eric W Hewitt
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

8.  High-Throughput Identification of MHC Class I Binding Peptides Using an Ultradense Peptide Array.

Authors:  Amelia K Haj; Meghan E Breitbach; David A Baker; Mariel S Mohns; Gage K Moreno; Nancy A Wilson; Victor Lyamichev; Jigar Patel; Kim L Weisgrau; Dawn M Dudley; David H O'Connor
Journal:  J Immunol       Date:  2020-02-14       Impact factor: 5.422

9.  Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus.

Authors:  Tony Schountz; Joseph Prescott; Ann C Cogswell; Lauren Oko; Katy Mirowsky-Garcia; Alejandra P Galvez; Brian Hjelle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

Review 10.  Molecular mechanisms of viral oncogenesis in humans.

Authors:  Nathan A Krump; Jianxin You
Journal:  Nat Rev Microbiol       Date:  2018-11       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.